Impact of conjugate pneumococcal vaccines on antibiotic resistance

Dagan, 2008, Seasonality of antibiotic-resistant S pneumoniae causing acute otitis media: a clue for antibiotic restriction policy?, J Infect Dis, 7, 1094, 10.1086/528995 2004 Jacobs, 2001, Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters, Clin Microbiol Infect, 7, 589, 10.1046/j.1198-743x.2001.00295.x 2008 Hansman, 1967, Resistant pneumococcus, Lancet, 2, 264, 10.1016/S0140-6736(67)92346-X Jacobs, 2003, The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents, J Antimicrob Chemother, 52, 229, 10.1093/jac/dkg321 Song, 2004, High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study), Antimicrob Agents Chemother, 48, 2101, 10.1128/AAC.48.6.2101-2107.2004 Bronzwaer, 2002, A European study on the relationship between antimicrobial use and antimicrobial resistance, Emerg Infect Dis, 8, 278, 10.3201/eid0803.010192 Goossens, 2005, Outpatient antibiotic use in Europe and association with resistance: a cross-national database study, Lancet, 365, 579, 10.1016/S0140-6736(05)17907-0 Harbarth, 2002, Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective, Emerg Infect Dis, 8, 1460, 10.3201/eid0812.010533 Arason, 1996, Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study, BMJ, 313, 387, 10.1136/bmj.313.7054.387 Bedos, 1996, Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey, Clin Infect Dis, 22, 63, 10.1093/clinids/22.1.63 Brandileone, 2006, Increase in numbers of beta-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage, J Med Microbiol, 55, 567, 10.1099/jmm.0.46387-0 Hogberg, 2007, Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci, J Clin Microbiol, 45, 948, 10.1128/JCM.01913-06 Chen, 1999, Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network, N Engl J Med, 341, 233, 10.1056/NEJM199907223410403 Ho, 2001, Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study, Clin Infect Dis, 32, 701, 10.1086/319222 Dias, 2004, Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14, J Antimicrob Chemother, 54, 1035, 10.1093/jac/dkh469 Vanderkooi, 2005, Predicting antimicrobial resistance in invasive pneumococcal infections, Clin Infect Dis, 40, 1288, 10.1086/429242 McGee, 2001, Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network, J Clin Microbiol, 39, 2565, 10.1128/JCM.39.7.2565-2571.2001 Gherardi, 2000, Major related sets of antibiotic-resistant pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles, J Infect Dis, 181, 216, 10.1086/315194 Käyhty, 2006, Nasopharyngeal colonization: a target for pneumococcal vaccination, Expert Rev Vaccines, 5, 651, 10.1586/14760584.5.5.651 Hendley, 1975, Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types, J Infect Dis, 132, 55, 10.1093/infdis/132.1.55 O'Brien, 2003, The potential indirect effect of conjugate pneumococcal vaccines, Vaccine, 21, 1815, 10.1016/S0264-410X(02)00807-1 Lipsitch, 2001, Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae, Clin Infect Dis, 32, 1044, 10.1086/319604 Yagupsky, 1998, Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel, J Infect Dis, 177, 1003, 10.1086/515239 Givon-Lavi, 1999, Marked differences in pneumococcal carriage and resistance patterns between day care centers located within a small area, Clin Infect Dis, 29, 1274, 10.1086/313465 Ussery, 1996, Risk factors for nasopharyngeal carriage of resistant Streptococcus pneumoniae and detection of a multiply resistant clone among children living in the Yukon-Kuskokwim Delta region of Alaska, Pediatr Infect Dis J, 15, 986, 10.1097/00006454-199611000-00011 Regev-Yochay, 2003, Independent risk factors for carriage of penicillin-non-susceptible Streptococcus pneumoniae, Scand J Infect Dis, 35, 219, 10.1080/00365540310000319 Syrogiannopoulos, 1997, Resistance patterns of Streptococcus pneumoniae from carriers attending day-care centers in southwestern Greece, Clin Infect Dis, 25, 188, 10.1086/514526 De Lencastre, 1999, Carriage of respiratory tract pathogens and molecular epidemiology of Streptococcus pneumoniae colonization in healthy children attending day care centers in Lisbon, Portugal, Microb Drug Resist, 5, 19, 10.1089/mdr.1999.5.19 Kellner, 1999, Streptococcus pneumoniae carriage in children attending 59 Canadian child care centers. Toronto Child Care Centre Study Group, Arch Pediatr Adolesc Med, 153, 495, 10.1001/archpedi.153.5.495 Klugman, 2001, Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance, Lancet Infect Dis, 1, 85, 10.1016/S1473-3099(01)00063-9 Klugman, 2003, A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection, N Engl J Med, 349, 1341, 10.1056/NEJMoa035060 Whitney, 2003, Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine, N Engl J Med, 348, 1737, 10.1056/NEJMoa022823 Whitney, 2006, Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study, Lancet, 368, 1495, 10.1016/S0140-6736(06)69637-2 Kaplan, 2004, Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine, Pediatrics, 113, 443, 10.1542/peds.113.3.443 Talbot, 2004, Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine, Clin Infect Dis, 39, 641, 10.1086/422653 Stephens, 2005, Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment, Lancet, 365, 855, 10.1016/S0140-6736(05)71043-6 Hennessy, 2005, Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity, Vaccine, 23, 5464, 10.1016/j.vaccine.2005.08.100 Kyaw, 2006, Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae, N Engl J Med, 354, 1455, 10.1056/NEJMoa051642 Hicks, 2007, Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004, J Infect Dis, 196, 1346, 10.1086/521626 Byington, 2005, Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups, Clin Infect Dis, 41, 21, 10.1086/430604 Porat, 2004, Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine, J Infect Dis, 190, 2154, 10.1086/425908 Porat, 2004, Four antibiotic resistant S pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel, J Infect Dis, 189, 385, 10.1086/381183 Frazao, 2005, Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon, Pediatr Infect Dis J, 24, 243, 10.1097/01.inf.0000154326.77617.3e Moore, 2004, Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska, J Infect Dis, 190, 2031, 10.1086/425422 Tempest, 1974, Distribution of the sensitivities to penicillin of types of Diplococcus pneumoniae in an American Indian population, J Infect Dis, 130, 67, 10.1093/infdis/130.1.67 Pai, 2005, Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States, J Infect Dis, 192, 1988, 10.1086/498043 Beall, 2006, Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002, J Clin Microbiol, 44, 999, 10.1128/JCM.44.3.999-1017.2006 Singleton, 2007, Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage, JAMA, 297, 1784, 10.1001/jama.297.16.1784 Steenhoff, 2006, Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia, Clin Infect Dis, 42, 907, 10.1086/500941 Beall, 2007, Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting, Expert Rev Vaccines, 6, 297, 10.1586/14760584.6.3.297 Messina, 2007, Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005, Pediatr Infect Dis J, 26, 461, 10.1097/INF.0b013e31805cdbeb Pelton, 2007, Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine, Pediatr Infect Dis J, 26, 468, 10.1097/INF.0b013e31803df9ca Moore, 2008, Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005, J Infect Dis, 197, 1016, 10.1086/528996 Hanage, 2007, Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era, J Infect Dis, 195, 347, 10.1086/510249 Regelmann, 2005, A pain in the ear: what has the 7-valent conjugated pneumococcal vaccine done to reduce the incidence of acute otitis media?, Clin Infect Dis, 40, 1745, 10.1086/429925 Eskola, 2001, Efficacy of a pneumococcal conjugate vaccine against acute otitis media, N Engl J Med, 344, 403, 10.1056/NEJM200102083440602 Kilpi, 2003, Clin Infect Dis, 37, 1155, 10.1086/378744 Black, 2000, Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children, Pediatr Infect Dis J, 19, 187, 10.1097/00006454-200003000-00003 Poehling, 2007, Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine, Pediatrics, 119, 707, 10.1542/peds.2006-2138 Zhou, 2008, Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997–2004, Pediatrics, 121, 253, 10.1542/peds.2007-0619 Joloba, 2001, Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media, Clin Infect Dis, 33, 1489, 10.1086/323027 Dagan, 2000, Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines, J Infect Dis, 181, 1322, 10.1086/315383 Block, 2004, Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media, Pediatr Infect Dis J, 23, 829, 10.1097/01.inf.0000136868.91756.80 Casey, 2004, Changes in frequency and pathogens causing acute otitis media in 1995–2003, Pediatr Infect Dis J, 23, 824, 10.1097/01.inf.0000136871.51792.19 McEllistrem, 2005, Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine, Clin Infect Dis, 40, 1738, 10.1086/429908 Huang, 2005, Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004, Pediatrics, 116, e408, 10.1542/peds.2004-2338 Grivea, 2008, Impact of heptavalent pneumococcal conjugate vaccine on nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among day-care center attendees in central Greece, Pediatr Infect Dis J, 27, 519, 10.1097/INF.0b013e318168d28a Park, 2008, Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children, Pediatr Infect Dis J, 27, 335, 10.1097/INF.0b013e318161434d Hammitt, 2006, Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease, J Infect Dis, 193, 1487, 10.1086/503805 Flannery, 2006, Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization, Ann Intern Med, 144, 1, 10.7326/0003-4819-144-1-200601030-00004 Cohen, 2006, Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media, Pediatr Infect Dis J, 25, 1001, 10.1097/01.inf.0000243163.85163.a8 Farrell, 2007, Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States, Pediatr Infect Dis J, 26, 123, 10.1097/01.inf.0000253059.84602.c3 Toltzis, 2006, Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American city, Pediatr Infect Dis J, 25, 19, 10.1097/01.inf.0000195784.27503.f0 Pichichero, 2007, Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children, JAMA, 298, 1772, 10.1001/jama.298.15.1772 Dagan R, Givon-Lavi N, Leibovitz E, Greenberg D, Porat N. Introduction and expansion of multidrug-resistant Streptococcus pneumoniae serotype 19A clones causing acute otitis media in an unvaccinated population. J Infect Dis (in press). Dagan, 2002, Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers, J Infect Dis, 185, 927, 10.1086/339525 Dagan, 1996, Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine, J Infect Dis, 174, 1271, 10.1093/infdis/174.6.1271 Dagan, 2003, Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day care centers, Pediatr Infect Dis J, 22, 532, 10.1097/01.inf.0000069761.11093.c3 Dagan, 1997, Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid, Pediatr Infect Dis J, 16, 1060, 10.1097/00006454-199711000-00011 Dagan R, Zamir O, Tirosh N, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in toddlers vaccinated during infancy with an 11 valent pneumococcal vaccine conjugated to diphtheria and tetanus toxoids. Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; Toronto, Canada; Sept 17–20, 2000. Abstract 236. Mbelle, 1999, Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine, J Infect Dis, 180, 1171, 10.1086/315009 Givon-Lavi, 2003, Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings, Pediatr Infect Dis J, 22, 524, 10.1097/01.inf.0000069760.65826.f2 Black, 2004, Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente, Pediatr Infect Dis J, 23, 485, 10.1097/01.inf.0000129685.04847.94 Dagan, 2000, Treatment of acute otitis media: challenges in the era of antibiotic resistance, Vaccine, 19, S9, 10.1016/S0264-410X(00)00272-3 Low, 2005, Changing trends in antimicrobial-resistant pneumococci: it's not all bad news, Clin Infect Dis, 41, S228, 10.1086/430782 Finkelstein, 2003, Reduction in antibiotic use among US children, 1996–2000, Pediatrics, 112, 620, 10.1542/peds.112.3.620 Halasa, 2002, Decreased number of antibiotic prescriptions in office-based settings from 1993 to 1999 in children less than five years of age, Pediatr Infect Dis J, 21, 1023, 10.1097/00006454-200211000-00009 Arnold, 2006, Decline in inappropriate antibiotic use over a decade by pediatricians in a Tennessee community, Ambul Pediatr, 6, 225, 10.1016/j.ambp.2006.04.005 Perz, 2002, Changes in antibiotic prescribing for children after a community-wide campaign, JAMA, 287, 3103, 10.1001/jama.287.23.3103 Fireman, 2003, Impact of the pneumococcal conjugate vaccine on otitis media, Pediatr Infect Dis J, 22, 10, 10.1097/00006454-200301000-00006 Dagan, 2001, Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees, Pediatr Infect Dis J, 20, 951, 10.1097/00006454-200110000-00008 Stoll, 2004, Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center, Arch Pediatr Adolesc Med, 158, 671, 10.1001/archpedi.158.7.671 Gabriel, 2004, Management of febrile children in the conjugate pneumococcal vaccine era, Clin Pediatr (Phila), 43, 75, 10.1177/000992280404300110 Temime, 2005, Penicillin-resistant pneumococcal meningitis: high antibiotic exposure impedes new vaccine protection, Epidemiol Infect, 133, 493, 10.1017/S0950268804003565 Temime, 2004, Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance, Antimicrob Agents Chemother, 48, 2206, 10.1128/AAC.48.6.2206-2213.2004 Dagan, 2005, Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus, J Infect Dis, 192, 367, 10.1086/431679 Millar, 2007, Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine, Clin Infect Dis, 44, 1173, 10.1086/513199 Jokinen, 2004, Concentration of anti-pneumococcal antibodies as a serological correlate of protection: an application to acute otitis media, J Infect Dis, 190, 545, 10.1086/422531 Park, 2007, Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae, J Clin Microbiol, 45, 1225, 10.1128/JCM.02199-06 du Plessis, 2008, Serotype 6C is associated with penicillin-susceptible meningeal infections in human immunodeficiency virus (HIV)-infected adults among invasive pneumococcal isolates previously identified as serotype 6A in South Africa, Int J Antimicrob Agents, 10.1016/j.ijantimicag.2008.06.002 Scott, 2007, Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults, Vaccine, 25, 6164, 10.1016/j.vaccine.2007.06.004 Malhotra-Kumar, 2007, Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study, Lancet, 369, 482, 10.1016/S0140-6736(07)60235-9